Loading clinical trials...
Loading clinical trials...
This randomized controlled trial will test a computerized cognitive bias modification program (CBM) to treat attention and interpretive biases in patients with primary aggression.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Temple University
NCT06804525 · Major Depressive Episode (MDE), Major Depressive Disorder (MDD), and more
NCT06665074 · Intermittent Explosive Disorder
NCT02055638 · Intermittent Explosive Disorder
NCT00078754 · Intermittent Explosive Disorder
NCT02048241 · Intermittent Explosive Disorder, Childhood Aggression, and more
Temple University
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions